BTIG analyst Mark Massaro raised the price target on GeneDx (NASDAQ: WGS) to $45.00 (from $35.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

GeneDx Holdings (WGS) Misses Q2 EPS by 46c; offers guidanceJuly 30, 2024 5:35 PM Form 10-Q GeneDx Holdings Corp. For: Jun 30July 30, 2024 4:20 PM Form 8-K GeneDx Holdings Corp. For: Jul 30July 30, 2024 4:13 PM GeneDx Reports Second Quarter 2024 Financial Results and Business HighlightsJuly 30, 2024 4:05 PM GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More PatientsJuly 30, 2024 4:05 PM